Contact
Please use this form to send email to PR contact of this press release:
Keros Therapeutics Presents Preclinical Data from its KER-012 Program at the American Heart Association 2022 Scientific Sessions
TO:
Please use this form to send email to PR contact of this press release:
Keros Therapeutics Presents Preclinical Data from its KER-012 Program at the American Heart Association 2022 Scientific Sessions
TO: